Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema

NCT06881888 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Octreotide (drug)
DRUG: Placebo

Sponsor

University of Alabama at Birmingham